top of page

Lysergic Acid Diethylamide (LSD) as Treatment for Cluster Headache

About the study

NCT Trial Number

NCT03781128

The drug being studied

LSD

noun_Drug_2240951.png
noun_Institution_118530.png

Sponsored by

University Hospital, Basel, Switzerland

noun_date_3237048.png

Trial Start Date

Jan-19

noun_capsule_138144.png

About the participants

Age seeking

25 Years to 75 Years

gender

All

noun_Mental Health_2683241.png

Primary condition of volunteers accepted

Cluster Headache

noun_square_138133.png

Accepts healthy volunteers?

No

This study will investigate the effects of an oral LSD regimen of 3 sessions over 3 weeks(3 x 100 µg LSD in patients suffering from CH

Eyes Graffiti

Locations


Switzerland
Clinical Pharmacology & Toxicology, University Hospital Basel Recruiting
Basel, Switzerland, 4031

Contact: Matthias Liechti, Prof.
+41 61 328 68 68
matthias.liechti@usb.ch

Contact: Yasmin Schmid, Dr. med.
+41 61 328 68 66
yasmin.schmid@usb.ch

​

​

​

​

Get in contact

Find a study site convenient for you below, then email yourself the contact details and next steps

bottom of page